The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study.

Autor: Almeida ND; Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.; Health Technology Assessment Unit, McGill University Health Centre, Montreal, QC, Canada., Schiller I; Health Technology Assessment Unit, McGill University Health Centre, Montreal, QC, Canada.; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Center, Montreal, QC, Canada., Ke D; Translational Research in Respiratory Diseases, Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, QC, Canada., Sakr E; Translational Research in Respiratory Diseases, Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, QC, Canada., Plesa M; Translational Research in Respiratory Diseases, Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, QC, Canada., Vanamala S; Translational Research in Respiratory Diseases, Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, QC, Canada., Moneger AL; Translational Research in Respiratory Diseases, Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, QC, Canada., Bazan M; Translational Research in Respiratory Diseases, Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, QC, Canada., Lucchesi C; Translational Research in Respiratory Diseases, Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, QC, Canada., Wozniak N; Translational Research in Respiratory Diseases, Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, QC, Canada., Fritz JH; Goodman Cancer Centre, and Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada., Piccirillo CA; Infectious Diseases and Immunology in Global Health Program, Research Institute of Research Institute of the McGill University Health Center, and Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada., Pelchat M; Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology and University of Ottawa, Ottawa, ON, Canada., Arnold C; Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology and University of Ottawa, Ottawa, ON, Canada., Galipeau Y; Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology and University of Ottawa, Ottawa, ON, Canada., McCluskie PS; Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology and University of Ottawa, Ottawa, ON, Canada., Langlois MA; Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology and University of Ottawa, Ottawa, ON, Canada., Dasgupta K; Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Center, Montreal, QC, Canada., Mazer BD; Translational Research in Respiratory Diseases, Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, QC, Canada.; Department of Pediatrics, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Feb 16; Vol. 15, pp. 1330549. Date of Electronic Publication: 2024 Feb 16 (Print Publication: 2024).